Technical breakthrough · 11. January 2021
From Galvani' spark to the three-dimensional structure of ion channels, learn the fabulous history of unique transmembrane proteins
Technical breakthrough · 14. December 2020
Molecular dynamics of G protein-coupled receptors (GPCRs) and unique monoclonal antibody effectors and binders targeting GPCR.
Technical breakthrough · 28. November 2020
SYnAbs unique anti-androstanolone (anti-DHT) monoclonal antibodies of a pg sensitivity level and no cross-reactivity to free testosterone
Technical breakthrough · 14. November 2020
SYnAbs develops immuno-affinity columns to purify rat, mouse antibodies in serum culture conditions with high specificity and develops custom immuno-affinity columns on demand
Technical breakthrough · 06. November 2020
SYnAbs offers recombinant polyclonal antibodies production, oligoclonal and multiclonal antibody cocktails
Technical breakthrough · 26. October 2020
SYnAbs has developed IL-1β monoclonal antibodies and immunoassays (ELISA and ELISpot kits) to help you monitor the immune responses to diverse infections,
diagnose auto-inflammatory diseases,
and simply get the best out of your inflammation research.
Technical breakthrough · 24. October 2020
SYnabs develops surrogate antibodies for preclinical evaluation of therapeutic antibody candidates in mouse, rat, and guinea pig species.
Technical breakthrough · 17. October 2020
Combining the appropriate antigen synthesis, the design of particular carrier linked at the perfect attachment site, its proprietary adjuvant and the access to lymph nodes, SYnabs has developed an expertise in the generation of high affinity IgG monoclonal antibodies against glycans.
Technical breakthrough · 06. October 2020
TRAIL and TRAIL receptors (tumor-necrosis-factor related apoptosis-inducing ligand) SYnabs unique antibodies
Technical breakthrough · 06. October 2020
SYnabs HEK cell culture to produce viral vectors and recombinant proteins